Access to a variety of blood and non-blood human biofluids from healthy and ill individuals, as well as those obtained utilizing hundreds of different analytes with associated test results, is made possible through iBioSpecimen.
iBioSpecimen simplifies procurement, from clinical residual to banked and prospectively obtained human biofluids. In order to assist you in locating the ideal specimen and data match for your study, including samples with difficult-to-find patient characteristics, we offer to give access to a varied, global network of providers.
What biofluids do you need for your research? Let us know how we can help.
iBioSpecimen Marketplace is a fast, compliant, revolutionary one-stop access to millions of human biofluids and patients from a diverse network of providers
If you want, we can have it. Our large and growing network of partners connects EMR data directly to the iBioSpecimen Marketplace, enabling us to obtain biological samples with unique data for a wide variety of diseases reported for research. Below are some examples.
Liquid biopsies revolutionize diagnosis, prognosis and disease management, enabling earlier and safer disease detection. However, the availability of biological samples often hinders the development of biopsy human biofluids. Bridging the gap between doctors and scientists, iBioSpecimen increases access to the biological fluids and other biological samples needed to perform biopsies.
By partnering with iBioSpecimen you can access records of human biofluids and patients. This is made possible by our collaborative partners, including hospitals, biobanks, commercial laboratories, HIEs and other international hospitals.
Human biofluids refer to bodily fluids such as blood, serum, plasma, urine, saliva, cerebrospinal fluid, and others collected from individuals. They are used in research to study various aspects of health and disease.
Human biofluids contain valuable biomarkers and molecules that can provide insights into health, disease, and therapeutic interventions. They offer a non-invasive or minimally invasive way to access biological information.
Biofluids can be collected through methods like venipuncture (for blood), urine sampling, saliva collection, and lumbar puncture (for cerebrospinal fluid). Proper collection and handling techniques are crucial to maintain sample integrity.
Human biofluids can be used for a wide range of research purposes, including biomarker discovery, disease diagnosis, drug development, epidemiological studies, and monitoring treatment responses.
Biomarkers in biofluids can include proteins, nucleic acids (DNA and RNA), metabolites, hormones, and various other molecules that can indicate the presence of disease or response to treatment.
Researchers should follow strict ethical guidelines and obtain informed consent from donors. Proper safety measures, including handling potentially infectious materials, should be observed.
Biofluid samples are typically stored at low temperatures (e.g., -80°C) to preserve the integrity of the biomolecules within them. Proper labeling and documentation are essential.
Challenges may include sample variability, the need for standardized collection methods, and ethical considerations regarding sample acquisition and consent.
Yes, DNA and RNA can be extracted from biofluids like blood and saliva for genetic research, including genotyping and gene expression analysis.
Yes, privacy and confidentiality are paramount when handling human biofluid samples. Researchers must ensure that donor information is protected and that samples are anonymized or de-identified as necessary.
Yes, biofluid samples can be shared for collaborative research, but this should be done in compliance with ethical and legal regulations and with proper informed consent.
Human biofluids have the potential to play a significant role in personalized medicine by providing insights into an individual’s unique biomolecular profile, helping tailor treatments and interventions.